Every 60 seconds, a child dies from malaria.
In addition to loss of life, malaria puts a huge strain on health systems, accounting for 40 percent of public health costs in many low- and middle-income countries. In addition, malaria impacts productivity, leading to school and work absenteeism and relegating many to a life of poverty.
Fortunately, there are effective ways to prevent and treat malaria, including long-lasting insecticide-treated bed nets (LLINs), which have contributed to a 20 percent decline in malaria deaths, and rapid diagnostic tests for malaria, which offer the potential for a fast, inexpensive and accurate method of diagnosing malaria. But inefficient markets for key malaria prevention and diagnostic interventions and decreasing foreign assistance for health present challenges for countries as they attempt to sustain and scale up malaria prevention and treatment efforts.
Countries must mobilize additional resources and maximize efficiencies of markets for critical malaria commodities.
R4D supports global and local change agents — global donors, government officials, civil society leaders and social innovators — as they work toward the eradication of malaria by:
Aspiration to Action
R4D built on the cost analyses included in the Aspiration to Action report by analyzing which financing approaches malaria-endemic countries might employ to close the funding gap and eliminate malaria.
- Completing costing analyses and developing financing scenarios.
- Examining and addressing market drivers and barriers in order to increase access to vital commodities.
- Working with all market stakeholders to identify opportunities for greater efficiencies and value for the money spent on malaria interventions.
Photo © Maggie Hallahan/Sumitomo Chemical